✦ LIBER ✦

Magnesium in the management of catecholaminesecreting glomus tumours with intracranial extension

✍ Scribed by Colin M Goutcher; Dora F Cossar; Urmila Ratnasabapathy; Anne M Burke

Publisher: Springer-Verlag
Year: 2006
Tongue: French
Weight: 133 KB
Volume: 53
Category: Article
ISSN: 1496-8975
DOI: 10.1007/bf03022221

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Has modern management improved the outco

Has modern management improved the outcome of infants with intracranial tumours?

✍ Rakesh Kumar; R. A. C. Jones; Ismail H. Tekkök 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 365 KB

Measurement of psychological distress in

Measurement of psychological distress in patients with intracranial tumours: the NCCN distress thermometer

✍ Simone Goebel; H. Maximilian Mehdorn 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 235 KB

The endovascular approach in the managem

The endovascular approach in the management of patients with multiple intracranial aneurysms

✍ L. Pierot; A. Boulin; L. Castaings; A. Rey; J. Moret 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 72 KB

Role of transsphenoidal operation in the

Role of transsphenoidal operation in the management of pituitary adenomas with suprasellar extension

✍ O. Bynke; J. Hillman 📂 Article 📅 1989 🏛 Springer Vienna 🌐 English ⚖ 589 KB

The role of endoscopic third ventriculos

The role of endoscopic third ventriculostomy in the management of hydrocephalus associated with cerebellopontine angle tumours

✍ C. Hayhurst; M. Javadpour; D. F. O’Brien; C. L. Mallucci 📂 Article 📅 2006 🏛 Springer Vienna 🌐 English ⚖ 86 KB

The value of tumour marker kinetics in t

The value of tumour marker kinetics in the management of patients with primary hepatocellular carcinoma

✍ Dr. P. K. Buamah; O. F. W. James; A. W. Skillen; A. L. Harris 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB

Serum alpha-fetoprotein (AFP) has been measured during chemotherapy of ten patients with hepatocellular carcinoma. Whenever the AFP concentration of a sample was lower than that of the previous sample the apparent half-life (AHL) of the protein was calculated. The biological half-life of AFP is 5 da